Novartis Investigative Site

Chambéry 73011

0 studies enrolling now · 2 studies all time

What they study most

Heart Failure With Reduced Ejection Fraction (HF-rEF), Primary Immune Thrombocytopenia (ITP)

Studies at this site

• Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) — Running, not enrolling
• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE